anurajms/meta_analysis huggingface dataset:
Provide patient population that should be included in the study
Single, double or multiple‐injection techniques for non‐ultrasound guided axillary brachial plexus block in adults undergoing surgery of the lower arm
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Disorder Of Upper Extremity
Provide patient population that should be included in the study
Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Haemorrhage 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Nitrous oxide‐based versus nitrous oxide‐free general anaesthesia and accidental awareness during general anaesthesia in surgical patients
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Surgery 7. Young Adult 19-24 years 8. General Anesthesia 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non‐cardiac surgery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Young Adult 19-24 years 6. Administration Of Anesthesia 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Local anaesthetic sympathetic blockade for complex regional pain syndrome
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Complex Regional Pain Syndrome 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Oxycodone for neuropathic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Neuropathic Pain 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Percutaneous techniques versus surgical techniques for tracheostomy
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Infant 1 to 23 mo 5. Critical Illness 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Adult 19-44 years 9. Middle Aged 45-64 years 10. Young Adult 19-24 years 11. Birth to 1 mo 12. Intubation 13. Mechanical ventilation
Provide patient population that should be included in the study
High initial concentration versus low initial concentration sevoflurane for inhalational induction of anaesthesia
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. General Anesthesia 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Paracetamol for low back pain
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Low back pain 4. Young Adult 19-24 years
Provide patient population that should be included in the study
Nutritional support for critically ill children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Critical Illness 5. Birth to 1 mo 6. Intensive Care 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Psychological preparation and postoperative outcomes for adults undergoing surgery under general anaesthesia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Elective Surgery 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. General Anesthesia 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Hydromorphone for neuropathic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Neuropathic Pain 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Midazolam for sedation before procedures
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Surgical And Medical Procedures 10. Aged 65-79 years 11. Adolescent 13-18 years 12. Diagnostic Procedure
Provide patient population that should be included in the study
Lateral positioning for critically ill adult patients
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Critical Illness 6. Aged 65-79 years
Provide patient population that should be included in the study
Topical NSAIDs for chronic musculoskeletal pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Musculoskeletal Pain 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Chronic Pain
Provide patient population that should be included in the study
Active body surface warming systems for preventing complications caused by inadvertent perioperative hypothermia in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Catheter impregnation, coating or bonding for reducing central venous catheter‐related infections in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Hospitalization 6. Central Venous Catheterisation 7. Aged 65-79 years
Provide patient population that should be included in the study
Spectral entropy monitoring for adults and children undergoing general anaesthesia
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Surgery 7. Young Adult 19-24 years 8. General Anesthesia 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Paravertebral block versus thoracic epidural for patients undergoing thoracotomy
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Thoracotomy 6. Aged 65-79 years
Provide patient population that should be included in the study
Lidocaine for reducing propofol‐induced pain on induction of anaesthesia in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. General Anesthesia 6. Propofol 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Vasopressors for hypotensive shock
1. Child, Preschool 2-5 years 2. Shock 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Critical Illness 9. Birth to 1 mo 10. Hypotensive 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Pharmacological and non‐pharmacological interventions for reducing rocuronium bromide induced pain on injection in children and adults
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Rocuronium 9. Birth to 1 mo 10. General Anesthesia 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Intranasal or transdermal nicotine for the treatment of postoperative pain
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Postoperative Pain 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Surgery 9. Young Adult 19-24 years 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Epidural pain relief versus systemic opioid‐based pain relief for abdominal aortic surgery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Procedure On Abdomen 5. Aortic Surgery 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Effectiveness and risks of cricoid pressure during rapid sequence induction for endotracheal intubation
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Surgery 8. Young Adult 19-24 years 9. Birth to 1 mo 10. General Anesthesia 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Prone position for acute respiratory failure in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Acute Respiratory Failure 5. Young Adult 19-24 years 6. Critical Illness 7. Intensive Care 8. Mechanical ventilation 9. Aged 65-79 years
Provide patient population that should be included in the study
Nitrous oxide‐based techniques versus nitrous oxide‐free techniques for general anaesthesia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Young Adult 19-24 years 6. General Anesthesia 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Rocuronium versus succinylcholine for rapid sequence induction intubation
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Intubation 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Non‐pharmacological interventions for sleep promotion in the intensive care unit
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Critical Illness 6. Intensive Care 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Ultrasound guidance for upper and lower limb blocks
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Regional analgesia for improvement of long‐term functional outcome after elective large joint replacement
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Implantation Of Joint Prosthesis 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Alpha‐2 adrenergic agonists for the prevention of shivering following general anaesthesia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Young Adult 19-24 years 6. General Anesthesia 7. Aged 65-79 years
Provide patient population that should be included in the study
Early versus late removal of the laryngeal mask airway (LMA) for general anaesthesia
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. General Anesthesia 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
The use of propofol for procedural sedation in emergency departments
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Emergency Care 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Sedation During Medical Procedure 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Lidocaine for preventing postoperative sore throat
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. General Anesthesia 6. Aged 65-79 years 7. Endotracheal intubation
Provide patient population that should be included in the study
Non‐pharmacological interventions for assisting the induction of anaesthesia in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Fear Of Anesthetic 5. General Anesthesia 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Peribulbar versus retrobulbar anaesthesia for cataract surgery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Cataract Surgery 6. Aged 65-79 years
Provide patient population that should be included in the study
The effects of high perioperative inspiratory oxygen fraction for adult surgical patients
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Exercise rehabilitation following intensive care unit discharge for recovery from critical illness
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Hospital discharge 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Critical Illness 7. Intensive Care 8. Mechanical ventilation 9. Aged 65-79 years 10. Extubation 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Tapentadol for chronic musculoskeletal pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Musculoskeletal Pain 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Warming of intravenous and irrigation fluids for preventing inadvertent perioperative hypothermia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Regional Anesthesia 4. Middle Aged 45-64 years 5. Surgery 6. Young Adult 19-24 years 7. General Anesthesia 8. Aged 65-79 years
Provide patient population that should be included in the study
Adrenaline with lidocaine for digital nerve blocks
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Procedure On Finger 9. Operative Procedure On Foot 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Zonisamide for neuropathic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years 7. Idiopathic Chronic Neuropathy
Provide patient population that should be included in the study
Ultrasound guidance versus anatomical landmarks for internal jugular vein catheterization
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Central Venous Catheterisation 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Ultrasound guidance versus anatomical landmarks for subclavian or femoral vein catheterization
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Central Venous Catheterisation 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Nortriptyline for neuropathic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Neuropathic Pain 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Chronic Pain
Provide patient population that should be included in the study
Conservative versus interventional management for primary spontaneous pneumothorax in adults
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Spontaneous Pneumothorax 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Intranasal fentanyl for the management of acute pain in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. Acute Pain 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Desipramine for neuropathic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Neuropathic Pain 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Chronic Pain
Provide patient population that should be included in the study
Effects of sevoflurane versus other general anaesthesia on emergence agitation in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Surgery 4. Adolescent 13-18 years
Provide patient population that should be included in the study
Botulinum toxin for myofascial pain syndromes in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Myofascial Pain Syndrome 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Topical lidocaine for neuropathic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Chronic central neuropathic pain 6. Aged 65-79 years
Provide patient population that should be included in the study
Air versus saline in the loss of resistance technique for identification of the epidural space
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Labor Established 5. Surgery 6. Young Adult 19-24 years 7. Pregnancy 8. Aged 65-79 years 9. Adolescent 13-18 years 10. Postoperative Analgesia
Provide patient population that should be included in the study
Mannitol versus hypertonic saline for brain relaxation in patients undergoing craniotomy
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Craniotomy 9. Brain neoplasm 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Physician anaesthetists versus non‐physician providers of anaesthesia for surgical patients
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Surgical patient 6. Aged 65-79 years
Provide patient population that should be included in the study
Daily sedation interruption versus no daily sedation interruption for critically ill adult patients requiring invasive mechanical ventilation
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Invasive Mechanical Ventilation 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Critical Illness 7. Sedated 8. Intensive Care 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Levetiracetam for neuropathic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Chronic central neuropathic pain 6. Aged 65-79 years
Provide patient population that should be included in the study
Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Congenital Heart Disease 4. Infant 1 to 23 mo 5. Pulmonary Hypertension 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Automated versus non‐automated weaning for reducing the duration of mechanical ventilation for critically ill adults and children
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Invasive Mechanical Ventilation 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Critical Illness 10. Intensive Care 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Pressure support versus T‐tube for weaning from mechanical ventilation in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Invasive Mechanical Ventilation 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Respiratory Failure 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Imipramine for neuropathic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Chronic central neuropathic pain 6. Aged 65-79 years
Provide patient population that should be included in the study
Heparin versus normal saline for patency of arterial lines
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Intensive Care 6. Aged 65-79 years
Provide patient population that should be included in the study
Permissive hypoxaemia versus normoxaemia for mechanically ventilated critically ill patients
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Critical Illness 9. Intensive Care 10. Mechanical ventilation 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Neostigmine for reversal of neuromuscular block in paediatric patients
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Neuromuscular Block Problem 5. Birth to 1 mo
Provide patient population that should be included in the study
High‐flow nasal cannula therapy for respiratory support in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Parenchymal Lung Disorders NEC 5. Upper airway obstruction 6. Critical Illness 7. Poor Respiratory Drive 8. Neuromuscular Disorder 9. Respiratory Failure 10. Mechanical ventilation 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Automated weaning and spontaneous breathing trial systems versus non‐automated weaning strategies for discontinuation time in invasively ventilated postoperative adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Invasive Mechanical Ventilation 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Intensive Care 7. Aged 65-79 years
Provide patient population that should be included in the study
Incentive spirometry for prevention of postoperative pulmonary complications in upper abdominal surgery
1. Abdominal surgery 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Intravenous versus inhalational anaesthesia for paediatric outpatient surgery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Paediatric Care 6. Aged 65-79 years 7. Outpatient Procedure
Provide patient population that should be included in the study
Continuous interscalene brachial plexus block versus parenteral analgesia for postoperative pain relief after major shoulder surgery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Postoperative Pain 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Shoulder operation 7. Aged 65-79 years
Provide patient population that should be included in the study
Fibrinogen concentrate in bleeding patients
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Haemorrhage 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Opioids for neuropathic pain
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Neuropathic Pain 6. Aged 65-79 years
Provide patient population that should be included in the study
Protocolized versus non‐protocolized weaning for reducing the duration of invasive mechanical ventilation in critically ill paediatric patients
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Invasive Mechanical Ventilation 4. Infant 1 to 23 mo 5. Critical Illness 6. Birth to 1 mo 7. Intensive Care 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Neuraxial anaesthesia for lower‐limb revascularization
1. Aged 80 and over 80+ years 2. Lower limb revascularization 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Surgery 6. Young Adult 19-24 years 7. Aged 65-79 years
Provide patient population that should be included in the study
Pharmacotherapy for the prevention of chronic pain after surgery in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Surgical Procedure On Soft Tissue 6. Young Adult 19-24 years 7. Aged 65-79 years
Provide patient population that should be included in the study
Intravenous versus inhalation anaesthesia for one‐lung ventilation
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Infant 1 to 23 mo 5. Aged 65-79 years 6. Adolescent 13-18 years 7. One-lung ventilation 8. Adult 19-44 years 9. Middle Aged 45-64 years 10. Surgery 11. Young Adult 19-24 years 12. Birth to 1 mo 13. Intensive Care 14. Mechanical ventilation
Provide patient population that should be included in the study
Single dose oral ibuprofen plus oxycodone for acute postoperative pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Acute Postoperative Pain
Provide patient population that should be included in the study
Single dose oral ibuprofen plus paracetamol (acetaminophen) for acute postoperative pain
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Acute Postoperative Pain
Provide patient population that should be included in the study
Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving mechanical ventilation in critical care units
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Invasive Mechanical Ventilation 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Critical Illness 7. Intensive Care 8. Aged 65-79 years
Provide patient population that should be included in the study
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus
1. Adult 19-44 years 2. Pregnant 3. Premature Delivery 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Eclampsia 6. Pre-eclampsia 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy
1. Fetal Growth Restriction 2. Pregnant
Provide patient population that should be included in the study
Planned hospital birth compared with planned home birth for pregnant women at low risk of complications
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Induction of labour at or near term for suspected fetal macrosomia
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Third Trimester Pregnancy 6. Adolescent 13-18 years 7. Fetal Macrosomia
Provide patient population that should be included in the study
Cervical pessary for preventing preterm birth in singleton pregnancies
1. Pregnant 2. Cervical Incompetence
Provide patient population that should be included in the study
Maternal postures for fetal malposition in labour for improving the health of mothers and their infants
1. Labor 2. Fetal Malposition
Provide patient population that should be included in the study
Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Preterm Spontaneous Labor With Preterm Delivery 6. Premature Labor 7. Preterm Premature Rupture Of Membranes 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. History of Steroid Therapy 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Routine vaginal examinations compared to other methods for assessing progress of labour to improve outcomes for women and babies at term
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Term Pregnancy 5. Labor 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for fear of childbirth including tocophobia
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Tocophobia 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Low‐dose oral misoprostol for induction of labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Induction Of Labor 6. Third Trimester Pregnancy Less Than 36 Weeks 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Methods for managing miscarriage: a network meta‐analysis
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Miscarriage 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section
1. Adult 19-44 years 2. Cesarean Section 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Complete Blood Count 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Umbilical vein injection for management of retained placenta
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Vaginal Delivery 5. Retained Placenta 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Oral non‐steroidal anti‐inflammatory drugs (single dose) for perineal pain in the early postpartum period
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Perineal Pain 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Paracetamol/acetaminophen (single administration) for perineal pain in the early postpartum period
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Perineal Pain 4. Young Adult 19-24 years 5. Pregnancy 6. Early Postpartum State 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth
1. Single Pregnancy 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Multigravida 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Multi‐professional simulation‐based team training in obstetric emergencies for improving patient outcomes and trainees' performance
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Healthcare Professional 4. Young Adult 19-24 years 5. Obstetric
Provide patient population that should be included in the study
Uterotonic agents for first‐line treatment of postpartum haemorrhage: a network meta‐analysis
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Postpartum Hemorrhage 4. Young Adult 19-24 years 5. Pregnancy 6. Third Trimester Pregnancy 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Intravenous versus intramuscular prophylactic oxytocin for reducing blood loss in the third stage of labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Vaginal Delivery 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Maintenance agonist treatments for opiate‐dependent pregnant women
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Opium Dependence 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Pregnancy 7. Aged 65-79 years
Provide patient population that should be included in the study
Interventions for preventing mastitis after childbirth
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Postpartum 4. Young Adult 19-24 years 5. Breast Fed 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Cervical stitch (cerclage) in combination with other treatments for preventing spontaneous preterm birth in singleton pregnancies
1. Single Pregnancy 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Second Trimester Pregnancy 5. Young Adult 19-24 years 6. Pregnancy 7. Cervical Incompetence 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Home versus inpatient induction of labour for improving birth outcomes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Viable Fetus 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Aspirin (single dose) for perineal pain in the early postpartum period
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Perineal Pain 4. Postpartum 5. Young Adult 19-24 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Induction of labour at or beyond 37 weeks' gestation
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Post-term Pregnancy 4. Young Adult 19-24 years 5. Term Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Techniques for preventing hypotension during spinal anaesthesia for caesarean section
1. Adult 19-44 years 2. Cesarean Section 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Spinal Analgesia 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Mechanical and surgical interventions for treating primary postpartum haemorrhage
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Postpartum Hemorrhage 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Skin preparation for preventing infection following caesarean section
1. Adult 19-44 years 2. Cesarean Section 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Advance misoprostol distribution to pregnant women for preventing and treating postpartum haemorrhage
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Anaesthesia/analgesia for manual removal of retained placenta
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Second Trimester Pregnancy 4. Removal Retained Placenta 5. Young Adult 19-24 years 6. Pregnancy 7. Gestation Greater Than 20 Weeks 8. Vaginal Delivery 9. Third Trimester Pregnancy 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Strategies for optimising antenatal corticosteroid administration for women with anticipated preterm birth
1. Adult 19-44 years 2. Premature Delivery 3. Middle Aged 45-64 years 4. Healthcare Professional 5. Young Adult 19-24 years 6. Pregnancy 7. Birth to 1 mo 8. Preterm Infant 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
1. Adult 19-44 years 2. Antiphospholipid Antibodies Positive 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Pregnancy Loss 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections
1. Adult 19-44 years 2. Cesarean Section 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Antibiotic prophylaxis for operative vaginal delivery
1. Adult 19-44 years 2. Forceps Delivery 3. Middle Aged 45-64 years 4. Vacuum Assisted Vaginal Delivery 5. Young Adult 19-24 years 6. Pregnancy 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Pharmacological interventions for promoting smoking cessation during pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Smoker 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology
1. Adult 19-44 years 2. First Trimester Pregnancy 3. Middle Aged 45-64 years 4. Second Trimester Pregnancy 5. Young Adult 19-24 years 6. Recurrent Miscarriage 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Antiplatelet agents for preventing pre‐eclampsia and its complications
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Cervical assessment by ultrasound for preventing preterm delivery
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for supporting the initiation and continuation of breastfeeding among women who are overweight or obese
1. Adult 19-44 years 2. Obesity 3. Middle Aged 45-64 years 4. Lactating Breast 5. Young Adult 19-24 years 6. Pregnancy 7. Adolescent 13-18 years 8. Overweight
Provide patient population that should be included in the study
Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes
1. Birth to 1 mo 2. Preterm Infant
Provide patient population that should be included in the study
Fetal fibronectin testing for reducing the risk of preterm birth
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Second Trimester Pregnancy 4. Young Adult 19-24 years 5. Pregnancy 6. Third Trimester Pregnancy 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Vaginal Delivery 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Active versus expectant management for women in the third stage of labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Uterotonic agents for preventing postpartum haemorrhage: a network meta‐analysis
1. Adult 19-44 years 2. Cesarean Section 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Vaginal Delivery 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Care prior to and during subsequent pregnancies following stillbirth for improving outcomes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Stillbirth 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventionist versus expectant care for severe pre‐eclampsia between 24 and 34 weeks' gestation
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Severe Pre-eclampsia 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Methods for blood loss estimation after vaginal birth
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Third Stage Of Labor 4. Young Adult 19-24 years 5. Pregnancy 6. Post-term Delivery 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Discontinuation of intravenous oxytocin in the active phase of induced labour
1. Adult 19-44 years 2. Labour Induction 3. Middle Aged 45-64 years 4. Oxytocin Measurement 5. Young Adult 19-24 years 6. Pregnancy 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Progestogen for treating threatened miscarriage
1. Adult 19-44 years 2. Viable Pregnancy 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Threatened Miscarriage In Second Trimester 6. Threatened Miscarriage In First Trimester 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Acute tocolysis for uterine tachysystole or suspected fetal distress
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Nonreassuring Fetal Status 6. Uterine Contractions Problem 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Parenteral opioids for maternal pain management in labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Labor Established 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for investigating and identifying the causes of stillbirth
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Stillbirth 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Antifibrinolytic drugs for treating primary postpartum haemorrhage
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Second Trimester Pregnancy 4. Postpartum Hemorrhage 5. Young Adult 19-24 years 6. Pregnancy 7. Third Trimester Pregnancy 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Term Pregnancy 5. Gestational Diabetes Mellitus 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Antenatal maternal education for improving postnatal perineal healing for women who have birthed in a hospital setting
1. Adult 19-44 years 2. Episiotomy 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Second Degree Perineal Tear During Delivery - Delivered 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Regimens of ultrasound surveillance for twin pregnancies for improving outcomes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Twin Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Antibiotic prophylaxis for episiotomy repair following vaginal birth
1. Adult 19-44 years 2. Episiotomy 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Vaginal Delivery 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for treating genital Chlamydia trachomatis infection in pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Chlamydia Trachomatis Infection 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Amniocentesis and chorionic villus sampling for prenatal diagnosis
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Genetic Disorder Carrier 4. Young Adult 19-24 years 5. Pregnancy 6. Fetus With Chromosomal Abnormality 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Gestational Diabetes Mellitus 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Elective repeat caesarean section versus induction of labour for women with a previous caesarean birth
1. Adult 19-44 years 2. Previous Caesarean Section 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Perineal techniques during the second stage of labour for reducing perineal trauma
1. Adult 19-44 years 2. Vertex Presentation 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Second stage of labor 7. Vaginal Delivery 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Fetal and umbilical Doppler ultrasound in high‐risk pregnancies
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. High Risk Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Treating periodontal disease for preventing adverse birth outcomes in pregnant women
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Periodontal Disease 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Methods of term labour induction for women with a previous caesarean section
1. Adult 19-44 years 2. Previous Caesarean Section 3. Labour Induction 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Third Trimester Pregnancy 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. High Risk Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Patient‐controlled analgesia with remifentanil versus alternative parenteral methods for pain management in labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Labor Established 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Pelvimetry for fetal cephalic presentations at or near term for deciding on mode of delivery
1. Adult 19-44 years 2. Previous Caesarean Section 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Fundal pressure during the second stage of labour
1. Adult 19-44 years 2. Vertex Presentation 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Second stage of labor 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Bed rest with and without hospitalisation in multiple pregnancy for improving perinatal outcomes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Multiple Pregnancy 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Iodine supplementation for women during the preconception, pregnancy and postpartum period
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Preterm Premature Rupture Of Membranes 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Breastfeeding education and support for women with twins or higher order multiples
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Multiple Pregnancy 4. Postpartum 5. Young Adult 19-24 years 6. Pregnancy 7. Adolescent 13-18 years